BCRX
BioCryst Pharmaceuticals, Inc.
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $962M | +117.9% |
| Gross profit | $941M | +120.9% |
| Operating income | −$289M | — |
| Net income | −$360M | — |
| EPS | −$1.42 | — |
| Free cash flow | $366M | — |
BioCryst Pharmaceuticals, Inc.
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $962M | +117.9% |
| Gross profit | $941M | +120.9% |
| Operating income | −$289M | — |
| Net income | −$360M | — |
| EPS | −$1.42 | — |
| Free cash flow | $366M | — |